Mazza Accelerated Transfer Speeds Manufacture of In-licensed Oncology Compound Challenge AAIPharma Services was called upon to accelerate transfer of an in-licensed anti-cancer compound. The pharmaceutical company sought release to the US and EU of Phase II immediate release tablets within five months of the Request for Proposal. Solution With limited information and using IND documentation, AAIPharma Services initiated an accelerated tr

Join for free to read